Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The advanced glycosylation end product (AGE) receptor encoded by AGER is a member of the immunoglobulin superfamily of cell surface receptors. Additionally we are shipping Advanced Glycosylation End Product-Specific Receptor Kits (77) and Advanced Glycosylation End Product-Specific Receptor Proteins (38) and many more products for this protein.
Showing 10 out of 299 products:
Cow (Bovine) Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN264840
Sugars, Karlström, Christersson, Olsson, Wendel, Fried: Expression of HMGB1 during tooth development. in Cell and tissue research 2007
Show all 5 references for ABIN264840
Human Polyclonal AGER Primary Antibody for IHC (p), WB - ABIN389027
Schlueter, Hauke, Flohr, Rogalla, Bullerdiek: Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing? in Biochimica et biophysica acta 2003
Show all 4 references for ABIN389027
Human Polyclonal AGER Primary Antibody for IF, IHC (p) - ABIN1108826
Bierhaus, Haslbeck, Humpert, Liliensiek, Dehmer, Morcos, Sayed, Andrassy, Schiekofer, Schneider, Schulz, Heuss, Neundörfer, Dierl, Huber, Tritschler, Schmidt, Schwaninger, Haering, Schleicher, Kasper et al.: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. ... in The Journal of clinical investigation 2004
Show all 4 references for ABIN1108826
Human Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN357685
Shanmugam, Kim, Lanting, Natarajan: Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. in The Journal of biological chemistry 2003
Show all 3 references for ABIN357685
Human Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN359696
Miyata, Akashi, Nishida: Molecular cloning and characterization of a novel member of the MAP kinase superfamily. in Genes to cells : devoted to molecular & cellular mechanisms 1999
Show all 2 references for ABIN359696
Human Polyclonal AGER Primary Antibody for IF, WB - ABIN390897
Peng, Lu, Wang, Yan, Chen, Zhang, Zhang, Shen: RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. in Archives of medical research 2009
Human Polyclonal AGER Primary Antibody for IHC, WB - ABIN2776917
Lieuw-a-Fa, Schalkwijk, Engelse, van Hinsbergh: Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs. in Thrombosis and haemostasis 2006
Human Polyclonal AGER Primary Antibody for WB - ABIN2776831
Galichet, Weibel, Heizmann: Calcium-regulated intramembrane proteolysis of the RAGE receptor. in Biochemical and biophysical research communications 2008
Human Polyclonal AGER Primary Antibody for FACS, IHC (p) - ABIN651054
Rojas, Figueroa, Morales: Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. in Carcinogenesis 2010
Reduced expression of membrane-bound AGER is a biomarker of multiple sclerosis disease progression.
up-regulated during platelet activation; binds high mobility group box 1 (show HMGB1 Antibodies) expressed in coronary artery thrombi
the G82S polymorphism in RAGE is associated with increased DRE (show SUFUH Antibodies) risk and that the GS genotype of the G82S locus is a risk factor for drug-resistant epilepsy in the Chinese population.
Compared with matched control placentas, the mRNA levels of HMGB1 (show HMGB1 Antibodies), RAGE and NF-kappaB (show NFKB1 Antibodies) p65 (show GORASP1 Antibodies) were increased in severe preeclamptic placentas.
Study confirms the involvement of HLA class III (HSP70 (show HSP70 Antibodies), RAGE, TNF (show TNF Antibodies)) in Alzheimer's Disease
Our data suggest that the presence of the A allele of -374 T/A polymorphism in the RAGE gene has a protective effect against stroke.
RAGE and TGF-beta1 (show TGFB1 Antibodies) are both involved in fibrosis development in a complex cross-talk mechanism, while also acting on their own individual targets
Study indicates a role for S100A12 (show S100A12 Antibodies), CML (show BCR Antibodies), and RAGE in peripheral arterial disease complications by activation of the RAGE system.
APE1/Ref-1 (show APEX1 Antibodies) is extracellularly secreted and triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation
activation of RAGE may influence the pathogenesis and reflection in sRAGE levels in acute and stable CAD (show CAD Antibodies) differently
Our results suggested that the increased RAGE expression in inflammatory circumstances and interaction with AGEs are risk factors in decreasing of aggrecan (show ACAN Antibodies) content in nucleus pulposus.
beta-Caryophyllene protects against GalN (show GAL Antibodies)/LPS (show TLR4 Antibodies)-induced liver injury through down-regulation of the TLR4 (show TLR4 Antibodies) and RAGE signaling.
AGER and its functions to stimulate O-GlcNAcylation are important during liver tumorigenesis, when high blood glucose levels are inadequately controlled.
HMGB1 (show HMGB1 Antibodies) and its main receptor, RAGE, appear to be crucial factors in the pathogenesis of TnI (show TNNI2 Antibodies)-induced experimental autoimmune myocarditis.
Only one fragment RAGE (60-76) was shown to have a therapeutic activity improving the memory state of bulbectomized mice and leads to decreasing in the level of brain beta-amyloid.
These data implicate RAGE as a modulator of both vasoreactivity and of proliferative processes in the response of the pulmonary circulation to chronic-hypoxia.
activation of the RAGE by advanced glycation end products or other ligands suppresses NIPP1 (show PPP1R8 Antibodies) expression in diabetic nephropathy, contributes to podocyte hypertrophy, and glomerular inflammation
RAGE-/- mice showed reduced inflammation, lower Th2 cytokine production from mononuclear cells, and lower numbers of group 2 innate lymphoid cells in the lung compared with RAGE+/+ mice.
Mice expressing RAGE on hematopoietic cells, but not radioresistant structural cells, showed reduced neutrophilia and emphysematous change in the lung.
RAGE has a role in pathogenesis of emphysema in mice.
RAGE enhances autophagy and neutrophil extracellular traps in pancreatic cancer.
The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847).
advanced glycosylation end product-specific receptor
, RAGE isoform NtRAGE-delta
, RAGE isoform sRAGE-delta
, advanced glycation end product receptor
, advanced glycosylation end product-specific receptor variant 1
, advanced glycosylation end product-specific receptor variant 3
, advanced glycosylation end product-specific receptor variant 4
, advanced glycosylation end product-specific receptor variant 5
, advanced glycosylation end product-specific receptor variant 6
, advanced glycosylation end product-specific receptor variant 7
, advanced glycosylation end product-specific receptor variant 8
, receptor for advanced glycosylation end products
, advanced glycation end-products receptor
, advanced glycosylation end product-specific receptor variant 2